| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8310532 | Clinica Chimica Acta | 2016 | 6 Pages |
Abstract
The overall analytical performance of Architect Pepsinogen I/II assay is acceptable for the detection of patients with suspected AG. The categorization results of gastric cancer risk showed some difference among test methods suggesting the need for harmonization among the methods from vendors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Eun-Jung Cho, Hyun-Ki Kim, Tae-Dong Jeong, Dae-Hyun Ko, Suh Eun Bae, Jong-Soo Lee, Woochang Lee, Jae Won Choe, Sail Chun, Hwoon-Yong Jung, Won-Ki Min,